中国生物制药(01177)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01177 中国生物制药

未开盘 06-17 16:08:37

4.600

-0.090

-1.92%

最高4.820	最低4.570	成交量7,389万
今开4.760	昨收4.690	日振幅5.33%
总市值860.43亿	流通市值860.43亿	总股本187.05亿
成交额3.42亿	换手率0.40%	流通股本187.05亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01177","market":"HK","secType":"STK","nameCN":"中国生物制药","latestPrice":4.6,"timestamp":1781683717004,"preClose":4.69,"halted":0,"volume":73894459,"delay":0,"changeRate":-0.019189765458422332,"floatShares":18705000000,"shares":18705000000,"eps":0.1504459056543165,"marketStatus":"未开盘","change":-0.09,"latestTime":"06-17 16:08:37","open":4.76,"high":4.82,"low":4.57,"amount":342292529,"amplitude":0.053305,"askPrice":4.6,"askSize":676000,"bidPrice":4.59,"bidSize":421000,"shortable":3,"etf":0,"ttmEps":0.1504459056543165,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781746200000},"marketStatusCode":0,"adr":0,"listingDate":1070812800000,"exchange":"SEHK","adjPreClose":4.69,"dividendRate":0.022623,"openAndCloseTimeList":[[1781659800000,1781668800000],[1781672400000,1781683200000]],"volumeRatio":0.843641,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SBO.HK","impliedVol":0.3877,"impliedVolPercentile":0.3984},"requestUrl":"/m/hq/s/01177","defaultTab":"news","newsList":[{"id":"2644710589","title":"中国生物制药(01177)：陈列平获委任为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2644710589","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644710589?lang=zh_cn&edition=full","pubTime":"2026-06-17 18:17","pubTimestamp":1781691479,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药(01177)发布公告，陈列平博士及鲁白博士获委任为独立非执行董事，自本公司于2026年6月17日召开及举行的股东周年大会结束起生效。董事会进一步宣布，紧随陈博士及鲁博士获委任后，(i)陈博士获委任为本公司审核委员会、薪酬委员会及提名委员会的成员;及(ii)鲁博士获委任为本公司审核委员会成员。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455631.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1589","IE00BZ08YS42.EUR","01177","BK1521","IE00BZ08YR35.GBP","BK1515","HK0000165453.HKD","BK1191","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194596234","title":"中国生物制药6月16日回购1051.2万股股份，耗资约4923.19万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194596234","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194596234?lang=zh_cn&edition=full","pubTime":"2026-06-16 16:52","pubTimestamp":1781599941,"startTime":"0","endTime":"0","summary":"中国生物制药于2026年6月16日在香港联交所场内回购普通股1051.2万股，约占该公司已发行股本的0.056%。回购价格每股介乎4.66港元至4.69港元，合共支付约4923.19万港元。根据披露，2025年6月10日公司通过了购回授权，授权可购回股份总数为1876071723股。公司确认此次交易严格遵守香港联合交易所有限公司证券上市规则及相关法律法规的要求。公告由公司秘书赖娟签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中国生物制药6月16日回购1051.2万股股份，耗资约4923.19万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643730898","title":"中国生物制药(01177)6月16日斥资4923.19万港元回购1051.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2643730898","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643730898?lang=zh_cn&edition=full","pubTime":"2026-06-16 16:49","pubTimestamp":1781599756,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药(01177)发布公告，于2026年6月16日斥资4923.19万港元回购1051.2万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1454940.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","01177","BK1589","IE00BZ08YS42.EUR","BK1191","BK1521","IE00BZ08YR35.GBP","HK0000165453.HKD","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176834501","title":"异动解读｜中国生物制药盘中下跌3.14%，制药板块持续承压叠加高沽空比例拖累","url":"https://stock-news.laohu8.com/highlight/detail?id=1176834501","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176834501?lang=zh_cn&edition=full","pubTime":"2026-06-16 10:23","pubTimestamp":1781576639,"startTime":"0","endTime":"0","summary":"6月16日，中国生物制药盘中下跌3.14%，报4.63港元，成交额1.11亿港元。消息面上，制药板块今日整体偏弱，同业石药集团跌3.4%，和黄医药跌2.35%，行业系统性抛压持续。此前摩根士丹利将公司目标价由8.3港元下调至7.8港元，维持增持评级，叠加近期公司沽空比率高达24.21%，空方力量较强，市场分歧显著。中国生物制药有限公司是一家主要从事制药业务的投资控股公司，业务涵盖中药现代制剂及西药的生产销售、长期投资及相关医疗业务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643781119","title":"中国生物制药(01177)：TQC2938“ST2单抗”于EAACI 2026公布II期临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2643781119","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643781119?lang=zh_cn&edition=full","pubTime":"2026-06-16 06:52","pubTimestamp":1781563928,"startTime":"0","endTime":"0","summary":"TQC2938的II期临床研究在SAR患者中取得了积极结果，有望为该类患者提供更优的治疗选择。TQC2938是全球首个在SAR治疗领域实现差异化布局并取得积极临床结果的ST2单抗。本次II期研究结果的公布，为其后续开展III期临床试验提供了坚实依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1454714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"中国生物制药(01177)：TQC2938“ST2单抗”于EAACI 2026公布II期临床数据","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BZ08YS42.EUR","HK0000165453.HKD","IE00BZ08YR35.GBP","BK1589","IE00BZ08YT58.USD","BK1521","BK1191","BK1515","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643822932","title":"【券商聚焦】交银国际：医药行业上半年表现整体稳健 下半年内部分化或加大","url":"https://stock-news.laohu8.com/highlight/detail?id=2643822932","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643822932?lang=zh_cn&edition=full","pubTime":"2026-06-15 10:21","pubTimestamp":1781490116,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指，医药行业在1H26表现整体稳健、但内部分化也较为明显。短期关注出海交易、业绩表现和利好政策落地。推荐高景气度赛道中、投资性价比较高的头部玩家，包括药明合联、凯莱英和康龙化成。2026年港股龙头收入和净利润增速有望稳定在双位数。板块复苏积极信号已经出现。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983754","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002562.SGD","LU0320764599.SGD","09966","IE00B0JY6N72.USD","LU0181495838.USD","LU0140636845.USD","09926","01276","03329","LU3063872942.SGD","LU0819121731.USD","BK1576","02096","06821","01177","01093","02269","LU1880383366.USD","LU2399975544.HKD","LU1960683339.HKD","HK0000320264.USD","01530","00013","06160","06990","LU0456827905.SGD","02162","01548","BK1191","03692","03759","09996","IE00BZ08YR35.GBP","LU0051755006.USD","LU0737861772.HKD","LU1688375341.USD","06078","02596","LU2097828631.EUR","02268","06996","LU1242518857.USD","LU0502904849.HKD","LU0348827113.USD","01801","01952","02273","LU1226287875.USD","01951","HK0000306685.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107095309","title":"异动解读｜中国生物制药盘中上涨3.19%，20亿港元回购计划提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1107095309","media":"行情直击","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107095309?lang=zh_cn&edition=full","pubTime":"2026-06-15 10:20","pubTimestamp":1781490017,"startTime":"0","endTime":"0","summary":"6月15日，中国生物制药盘中上涨3.19%，报4.85港元，成交额1.19亿港元。消息面上，公司公告董事会于6月12日议决通过一项股份购买计划，将于未来12个月内以不超过20亿港元总代价在公开市场回购股份及购买限制性股份奖励计划所需股份。年初至今，公司已累计购买6035万股，总代价约3.38亿港元。大额回购计划彰显管理层对公司价值的信心，有望对股价形成持续支撑。此外，制药板块同业石药集团今日涨2.62%，行业情绪整体偏暖。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643322546","title":"港股开盘向好 恒指高开1.15% 联想集团(00992)涨4.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643322546","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643322546?lang=zh_cn&edition=full","pubTime":"2026-06-15 09:26","pubTimestamp":1781486814,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股开盘向好，恒指高开1.15%，国企指数高开0.95%，恒生科技指数高开1.78%。联想集团涨4.92%，洛阳钼业涨4.79%，紫金矿业涨4.46%，中芯国际涨3.28%，中国宏桥涨3.19%。内地股市上周五上升，上证综合指数高开高走，重上4,000点关口，收市上升1.1%，沪深两市成交额亦显着增加。外围气氛良好，通胀预期回落有利大市反弹，预料指数可上试25,000点阻力，下方支持在24,000点水平。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/YjFmNjZjNDg2MTA4NTI1ODgwMzI4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/YjFmNjZjNDg2MTA4NTI1ODgwMzI4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983741","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348784397.USD","LU0329678337.USD","LU0266512127.USD","LU0797268264.HKD","IE00BQJZWZ67.USD","LU1497734951.SGD","MCHmain","HK0000252160.HKD","LU2929501877.USD","LU0096374516.USD","LU2097828631.EUR","LU0348827113.USD","LU0516422440.USD","LU1515016050.SGD","LU1769817096.USD","HK0000500386.USD","LU0348825331.USD","LU0972618739.USD","03037","07300","LU1366334578.USD","LU0890818403.SGD","SBHMY","LU0345780950.USD","BK1119","LU0918141705.HKD","LU1770034418.SGD","LU0417516902.SGD","LU1166156734.SGD","LU1051768304.USD","ZIJMY","513600","LU0791591158.USD","LU0348783233.USD","LU0211977185.USD","LU0918141887.USD","LU0149721374.USD","LU1634259391.SGD","NDGPY","BK1539","LU1880383440.USD","LU0307460666.USD","LU1831875114.USD","LU1235295612.USD","LU1481107354.HKD","LU0611395673.USD","LU0048580855.USD","SG9999006597.SGD","CSUAY","SG9999001093.SGD","SG9999004220.SGD","LU0886674414.USD","LU1366334651.USD","LU0877626530.USD","09115","LU1769817179.HKD","LU0049112450.USD","LU0264606111.USD","LU0345781412.USD","LU0348814723.USD","601857","LU0540923850.HKD","LU0871576103.HKD","82800","LU0456854461.SGD","SG9999002463.SGD","IE00B19Z5X02.USD","BK1515","BK1514","LU1267930227.SGD","LU1497733631.SGD","03115","BK1223","LU1064131003.USD","688981","LU0441854154.USD","LU0431992006.USD","LU2148510915.USD","BK1505","IE0034224299.USD","IE0032431581.USD","LU0328353924.USD","LU2097828474.EUR","LU1720050803.USD","LU0588545730.USD","LNVGY","LU1719994722.HKD","LU1251922891.USD","LU2008162690.USD","BK1163","02833","BK1526","BK1175","HSTECH","LU0862451837.USD","LU0164880469.USD","LU0314109678.HKD","LU1808992512.USD","LU1813983027.USD","LU0082770016.SGD","BK1521","LU0293314216.USD","BK1198","LU0516423174.USD","02899","LU2226246903.HKD","IE0008368742.USD","HSI","LU0702159699.USD","LU0828237510.HKD","LU0320764599.SGD","LU1785774172.SGD","LU2399975544.HKD","LU0181495838.USD","LU0173614495.USD","HK0000320223.HKD","LU1497733557.USD","LU0588545490.SGD","SG9999004311.SGD","02800","BK1575","BK1592","LU0345780281.USD","LU0228367735.SGD","LU0737861772.HKD","LU1282648689.USD","LU0205439572.USD","LU0672654166.SGD","LU0417516571.SGD","LU1242518857.USD","IE00BZ08YS42.EUR","LU0516423091.SGD","LU0828237940.HKD","BK1226","LU0052756011.USD","LU0039217434.USD","HK0000320264.USD","LU0572939691.SGD","LU0348766576.USD","LU0370786039.SGD","LU0140636845.USD","LU2242644610.SGD","IE00BZ08YR35.GBP","LU0737861699.HKD","02015","BK1500","LU0061477393.USD","LU1064130708.USD","SGXZ86797644.SGD","LU1188198961.HKD","07200","LU0164865239.USD","LU0128522157.USD","BK1588","LU2048586759.USD","HHImain","LU0029875118.USD","BK1544","LU0348735423.USD","LU0531971595.HKD","LU0865486749.SGD","LU2213484517.USD","LU3063872942.SGD","LU0405327494.USD","LU0165289439.USD","01088","00992","LU2097828557.USD","BK1221","LU2351347302.SGD","80992","03993","01177","03896","02688","LU0163747925.USD","LU0405327148.USD","LU0516422952.EUR","LU0469268626.HKD","LU0106252389.USD","LU0868486357.SGD","LU1115378108.SGD","LU0516422366.SGD","BK1551","LU1328277881.USD","BK1190","LU1023057109.AUD","600938","LU0348805143.USD","LU0359201612.USD","LU0862451753.SGD","HK0000306685.HKD","LU1105468828.SGD","80883","BK1538","LU1046422090.SGD","IE00BZ08YT58.USD","LU2177674079.SGD","LU2097828714.EUR","LU2328871848.SGD","02689","BK1587","LU0979878070.USD","HK0000165453.HKD","LU0791590937.USD","BK1238","LU0072462343.USD","LU0634319403.HKD","LU1880383366.USD","BK1614","LU1119993845.HKD","LU1303224171.USD","LU1988902786.USD","LU0359202008.SGD","BK1191","LU0049853897.USD","BK1566","01378","601088","HK0000306701.USD","HK0001040168.HKD","LU1981816686.USD","HK0000252152.HKD","603993","SG9999014674.SGD","LU1969619763.USD","LU0228659784.USD","LU0327786744.USD","LU1224444064.USD","LU1282651048.USD","LU1675838814.USD","LU0052750758.USD","LU0572940350.SGD","00981","IE00BWDBJ730.SGD","BK1610","LI","LU0463099449.HKD","LU1048588211.SGD","LU1522347837.USD","LU0244354667.USD","LU0326950275.SGD","LU0287142896.SGD","LU0348783662.USD","LU0588546209.SGD","LU2293587155.HKD","IE00B0JY6N72.USD","LU1504937902.USD","LU1048596156.SGD","LU0345780521.USD","LU1282651121.HKD","LU0417516738.SGD","KC","LU2097828805.USD","BK1589","LU0359201885.HKD","601899","LU0543330483.HKD","LU0630314457.HKD","LU0675040207.SGD","LU1634259557.SGD","LU2264538146.SGD","00883","XNGSY","SG9999003461.SGD","LU0620787316.HKD","HK0001040143.USD","LU0708995583.HKD","LU1224709979.USD","LU0128525689.USD","LU0348816934.USD","LU0320764755.SGD","03419","BK1528","BK1594","LU0310800965.SGD","LU1794554557.SGD","00857","LU0821914370.USD","BK1178","LU0561508036.HKD","BK1613","LU0043850808.USD","SG9999002950.SGD","SGXZ62798434.SGD","07500","83115","BK1193","LU0164939612.USD","BK1607","LU0588545904.SGD","LU0106959298.USD","LU1064131342.USD","LU0315178854.USD","LU0348767384.USD","LU0640798160.USD","LU0572944931.SGD","LU0651946864.USD","LU2039709279.SGD","LU0082770016.USD","LU0266512473.USD","LU1242518931.SGD","BK1134","LU2187417386.USD","LU1961090484.USD","LU0329678170.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643225389","title":"港股公告掘金 | 仙工智能、麦科医药启动招股 英硅智能获纳入中证指数系列","url":"https://stock-news.laohu8.com/highlight/detail?id=2643225389","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643225389?lang=zh_cn&edition=full","pubTime":"2026-06-15 09:05","pubTimestamp":1781485527,"startTime":"0","endTime":"0","summary":"【重大事项】仙工智能(06106)今起招股募资近10亿港元加码机器人研发 HHLRA、广发基金等八家机构入局基石麦科医药-B(02335)今起招股募资逾10亿港元 启源香港、云顶新耀(01952)等基石入局英硅智能(03696)获纳入中证指数系列瑞威资管(01835)拟合计 4000 万元收购两只智能驾驶主题基金合伙份额达力普控股(01921)获埃及通用石油公司万吨油井管订单中国生物制药(0117","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1454173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1589","BK1161","BK1191","HK0000165453.HKD","BK4588","BK1521","BK1515","BK1574","VXUS","159938","BK4585","IPOS","IE00BZ08YR35.GBP","09939","06106","IE00BZ08YT58.USD","01177","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643240994","title":"中国生物制药(01177)拟斥资不超过20亿港元用于股份回购及奖励股份购买","url":"https://stock-news.laohu8.com/highlight/detail?id=2643240994","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643240994?lang=zh_cn&edition=full","pubTime":"2026-06-15 06:06","pubTimestamp":1781474767,"startTime":"0","endTime":"0","summary":"董事会将不时检讨及全权酌情决定如何分配股份购买额度用于股份回购及奖励股份购买。董事会认为实施股份购买计划符合公司及其股东的整体最佳利益。董事会认为，公司现有充足财务资源足以实施股份购买计划并维持稳健的财务状况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1454111.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1589","IE00BZ08YT58.USD","BK1191","HK0000165453.HKD","BK1515","BK1521","IE00BZ08YR35.GBP","01177","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178904463","title":"异动解读 | 多重利好催化，中国生物制药盘中大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=1178904463","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178904463?lang=zh_cn&edition=full","pubTime":"2026-06-12 11:14","pubTimestamp":1781234099,"startTime":"0","endTime":"0","summary":"中国生物制药今日盘中大涨5.16%，引起了市场的广泛关注。消息面上，公司近日获世界经济论坛第三届“AI应用之星”项目认可，作为独立申报的医药企业成功跻身国际权威榜单，同时正式发布《绿色供应链倡议书》，推动产业链ESG发展。此外，旗下正大天晴全球研发总部在上海落成启用，总投资18亿元，公司还牵头成立上海生物医药企业国际化发展协会，强化出海布局。制药板块今日整体回暖，行业情绪修复带动个股反弹。摩根士丹利虽将公司目标价由8.3港元下调至7.8港元，但维持增持评级，为股价提供了一定支撑。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122085890","title":"异动解读｜中国生物制药盘中下跌3.08%，大摩下调目标价叠加制药板块持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1122085890","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122085890?lang=zh_cn&edition=full","pubTime":"2026-06-10 10:14","pubTimestamp":1781057658,"startTime":"0","endTime":"0","summary":"6月10日，中国生物制药盘中下跌3.08%，报4.4港元，成交额9594.56万港元。消息面上，摩根士丹利近期发布研报，将中国生物制药目标价由8.3港元下调至7.8港元，维持增持评级。此外，公司于6月4日注销4035万股已回购股份，回购均价5.471港元，总金额约2.21亿港元，注销后总股本降至约187.05亿股。制药板块今日整体偏弱，恒瑞医药跌2.08%，绿叶制药跌1.06%，和黄医药跌0.71%，行业系统性抛压加剧个股跌幅。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641101540","title":"港股异动 | 创新药概念股全线承压 流动性收紧直接压制板块估值 机构指BINSA草案影响偏情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=2641101540","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641101540?lang=zh_cn&edition=full","pubTime":"2026-06-08 15:08","pubTimestamp":1780902518,"startTime":"0","endTime":"0","summary":"消息面上，中东紧张局势推高能源价格之际，劳动力市场表现强劲，强化了市场对美联储年内加息的押注。国海证券此前在风险提示中指出，若全球及国内宏观货币政策节奏不及预期，将直接影响医药板块的估值水平与投融资环境。创新药、CXO等成长赛道对流动性较为敏感，若美联储降息周期延后，或国内降准降息落地不及预期，市场流动性收紧将直接压制成长赛道估值。此外，6月2日，美国《生物技术投资国家安全法》法案公布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1813983027.USD","LU1960683339.HKD","BK1574","LU1226287792.SGD","SG9999004220.SGD","IE00B5MMRT66.SGD","BK1593","BK1583","LU0502904849.HKD","LU1226288253.USD","LU1008478684.HKD","LU0314109678.HKD","IE00B031HY20.USD","06978","LU0067412154.USD","IE00BZ08YT58.USD","BK1515","BK1161","BK4588","LU0072913022.USD","LU1152091168.USD","01801","BK4585","01177","VXUS","LU2328871848.SGD","IE00B543WZ88.USD","LU1993786604.SGD","159992","LU0455707207.USD","LU0501845795.SGD","01530","LU1969619763.USD","LU2039709279.SGD","LU1226287875.USD","LU1328277881.USD","LU0140636845.USD","LU0880133367.SGD","LU1226288170.HKD","BK1191","LU1951186391.HKD","01093","HK0000165453.HKD","BK1589","LU2097828557.USD","LU2242644610.SGD","LU2097828631.EUR","LU2097828714.EUR","LU2488822045.USD","IE0008369823.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199633742","title":"异动解读｜中国生物制药盘中下跌3.22%，大摩下调目标价叠加制药板块持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1199633742","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199633742?lang=zh_cn&edition=full","pubTime":"2026-06-08 11:41","pubTimestamp":1780890110,"startTime":"0","endTime":"0","summary":"6月8日，中国生物制药盘中下跌3.22%，报4.51港元，成交额1.55亿港元。消息面上，摩根士丹利近期发布研报，将中国生物制药目标价由8.3港元下调至7.8港元，维持增持评级。该行纳入新引进授权的bepirovirsen，预计自2027年开始贡献收入，同时根据管理层指引移除来自Sinovac LS的股息收入假设，将2026至2028年每股盈利预测分别下调8%、7%及7%。此外，制药板块今日整体走弱，绿叶制药跌4.3%，恒瑞医药跌3.85%，石药集团跌3.45%，翰森制药跌2.39%，行业系统性抛压加剧个股跌幅。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143424293","title":"中国生物制药6月4日注销回购4035万股 涉资约2.21亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143424293","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143424293?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:42","pubTimestamp":1780562570,"startTime":"0","endTime":"0","summary":"中国生物制药有限公司（股票代码：01177）6月4日发布公告，确认注销于2026年4月21日至5月22日期间回购的40,350,000股普通股，占2026年5月31日公司已发行股本约0.215%。据公告披露，上述股份的每股回购价格为5.471港元，本次回购总金额约2.21亿港元。\n注销完成后，公司已发行股本由18,745,367,230股减少至18,705,017,230股，库藏股数量维持0股。中国生物制药有限公司表示，相关操作已遵守香港联交所证券上市规则及其他相关法律法规。公告由公司秘书赖娟签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"中国生物制药6月4日注销回购4035万股 涉资约2.21亿港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640538041","title":"中国生物制药(01177)注销4035万股已回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2640538041","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640538041?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:37","pubTimestamp":1780562236,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药(01177)发布公告，于2026年6月4日注销4035万股已回购股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450114.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01177","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","HK0000165453.HKD","BK1191","BK1589","BK1515","BK1521","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132022829","title":"异动解读｜中国生物制药盘中下跌3.14%，大摩下调目标价叠加制药板块持续承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1132022829","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132022829?lang=zh_cn&edition=full","pubTime":"2026-06-04 11:23","pubTimestamp":1780543418,"startTime":"0","endTime":"0","summary":"6月4日，中国生物制药盘中下跌3.14%，报4.62港元，成交额1.86亿港元。消息面上，摩根士丹利近日发布研报，将中国生物制药目标价由8.3港元下调至7.8港元，维持增持评级。该行纳入新引进授权的bepirovirsen，预计自2027年开始贡献收入，同时根据管理层指引移除来自Sinovac LS的股息收入假设，将2026至2028年每股盈利预测分别下调8%、7%及7%。此外，制药板块今日整体走弱，绿叶制药跌12.9%，恒瑞医药跌4.2%，先声药业跌2.24%，行业系统性抛压加剧个股跌幅。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115994961","title":"异动解读｜中国生物制药盘中下跌3.07%，大摩下调目标价叠加制药板块整体承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1115994961","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115994961?lang=zh_cn&edition=full","pubTime":"2026-06-03 10:17","pubTimestamp":1780453069,"startTime":"0","endTime":"0","summary":"6月3日，中国生物制药盘中下跌3.07%，报4.73港元，成交额6926.11万港元。消息面上，摩根士丹利近日发布研报，将中国生物制药目标价由8.3港元下调至7.8港元，维持增持评级。该行纳入新引进授权的bepirovirsen，预计自2027年开始贡献收入，同时根据管理层指引移除来自Sinovac LS的股息收入假设，将2026至2028年每股盈利预测分别下调8%、7%及7%。此外，制药板块今日整体走弱，石药集团跌5.02%，恒瑞医药跌4.08%，复星医药跌2.92%，行业系统性抛压加剧个股跌幅。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640999903","title":"中国生物制药(01177)盘中下跌1.41% 大摩下调其26-28年每股盈利预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2640999903","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640999903?lang=zh_cn&edition=full","pubTime":"2026-06-02 11:13","pubTimestamp":1780370000,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中国生物制药(01177)盘中走低，最新报4.88港元，下跌1.41%，成交额1.04亿港元。消息面上，大摩最新发布研报，将中国生物制药目标价由8.3元下调至7.8元，评级“增持”。该行表示，纳入新引进授权的bepirovirsen(HBVASO)，预计该产品将自2027年开始贡献收入。同时亦根据管理层指引，自2026年起移除对来自SinovacLS的股息收入假设。因此将2026至2028年的每股盈利预测分别下调8%、7%及7%。此外，同时调整了营运资金及资本开支假设，以更好地反映近期营运趋势。","market":"us","thumbnail":"https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/YzIxOTk5NDIxODE3ODE=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1982803","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","01177","BK1589","IE00BZ08YS42.EUR","BK1191","BK1521","IE00BZ08YR35.GBP","HK0000165453.HKD","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640717960","title":"中国生物制药(01177)：库莫西利“CDK2/4/6抑制剂”于2026 ASCO公布CDK4/6抑制剂经治人群II期临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2640717960","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640717960?lang=zh_cn&edition=full","pubTime":"2026-06-02 07:12","pubTimestamp":1780355543,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药 发布公告，集团附属公司正大天晴药业集团股份有限公司自主研发的国家1类创新药库莫西利“CDK2/4/6 抑制剂”于2026年美国临床肿瘤学会大会上公布一项在CDK4/6抑制剂经治人群中的II期临床研究数据。对于既往接受CDK4/6i治疗失败、且合并高比例内脏转移的患者而言，这一疗效结果具有重要临床意义。传统CDK4/6抑制剂最受关注的≥3级中性粒细胞减少发生率仅为5.7%，这一结果与其较低的CDK6抑制活性特征一致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448839.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01177","BK1521","BK1515","HK0000165453.HKD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","BK1589","BK1191","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinobiopharm.com","stockEarnings":[{"period":"1week","weight":0.0222},{"period":"1month","weight":-0.1321},{"period":"3month","weight":-0.2409},{"period":"6month","weight":-0.2998},{"period":"1year","weight":-0.0741},{"period":"ytd","weight":-0.2557}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":-0.0531},{"period":"3month","weight":-0.0466},{"period":"6month","weight":-0.0537},{"period":"1year","weight":0.0138},{"period":"ytd","weight":-0.0514}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中国生物制药有限公司是一家主要从事制药业务的投资控股公司。该公司通过三个分部运营。中药现代制剂及西药分部主要从事生产、销售及配销中药现代制剂及西药产品业务。投资分部主要从事长期投资业务。其他分部主要从事相关医疗及医院业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.434783,"avgChangeRate":0.008254},{"month":2,"riseRate":0.652174,"avgChangeRate":0.056687},{"month":3,"riseRate":0.565217,"avgChangeRate":0.045006},{"month":4,"riseRate":0.478261,"avgChangeRate":0.021296},{"month":5,"riseRate":0.695652,"avgChangeRate":0.038013},{"month":6,"riseRate":0.347826,"avgChangeRate":0.005756},{"month":7,"riseRate":0.636364,"avgChangeRate":0.047691},{"month":8,"riseRate":0.409091,"avgChangeRate":-0.010062},{"month":9,"riseRate":0.409091,"avgChangeRate":-0.015174},{"month":10,"riseRate":0.545455,"avgChangeRate":0.025184},{"month":11,"riseRate":0.5,"avgChangeRate":0.066781},{"month":12,"riseRate":0.409091,"avgChangeRate":-0.01175}],"exchange":"SEHK","name":"中国生物制药","nameEN":"SBP GROUP"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国生物制药(01177)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国生物制药(01177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国生物制药,01177,中国生物制药股票,中国生物制药股票老虎,中国生物制药股票老虎国际,中国生物制药行情,中国生物制药股票行情,中国生物制药股价,中国生物制药股市,中国生物制药股票价格,中国生物制药股票交易,中国生物制药股票购买,中国生物制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国生物制药(01177)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国生物制药(01177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}